Literature DB >> 17224646

Analysis of apoptosome dysregulation in pancreatic cancer and of its role in chemoresistance.

Marco Corvaro1, Claudia Fuoco, Martin Wagner, Francesco Cecconi.   

Abstract

The apoptosome is a multiprotein complex mediating the mitochondrial pathway of cell death. Its importance during development has been clearly demonstrated by knocking out key genes in mouse. APAF1 is the core protein of the apoptosome and its dosage is also critical in various cancer types, i.e., melanoma, germ line tumor, gastrointestinal cancer and B-type chronic lymphocytic leukemia. This is generally due to inactivation of the APAF1 locus by epigenetic phenomena or by activity of promoter regulators. We investigated the putative roles of the apoptosome in pancreatic ductal adenocarcinoma (PDAC). We found that both APAF1 mRNA and protein are dysregulated in human PDAC samples. Similarly, several PDAC cell lines exhibited variable levels of both APAF1 protein and mRNA. The response to cell death induction and its biochemical features were assessed by treatment of each line with commonly used chemotherapeutic agents. We found that the apoptosome pathway was not functional in most cell lines upon cytochrome c release from mitochondria. In addition, we restored APAF1 and Caspase-9 dosage in Panc-1 cells, where the apoptosome is downregulated, by overexpressing the murine cDNA of the two molecules, and we improved the death response to chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17224646     DOI: 10.4161/cbt.6.2.3622

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  7 in total

Review 1.  Mitochondrial and postmitochondrial survival signaling in cancer.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Mitochondrion       Date:  2013-12-10       Impact factor: 4.160

2.  Oncogenic miR-23a in Pancreatic Ductal Adenocarcinogenesis Via Inhibiting APAF1.

Authors:  Ning Liu; Yuan-Yuan Sun; Xiao-Wen Zhang; Sheng Chen; Ye Wang; Zhao-Xiong Zhang; Shao-Wei Song; Guang-Bin Qiu; Wei-Neng Fu
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

3.  Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.

Authors:  Marco Ragusa; Giuseppe Avola; Rosario Angelica; Davide Barbagallo; Maria Rosa Guglielmino; Laura R Duro; Alessandra Majorana; Luisa Statello; Loredana Salito; Carla Consoli; Maria Grazia Camuglia; Cinzia Di Pietro; Giuseppe Milone; Michele Purrello
Journal:  BMC Cancer       Date:  2010-07-19       Impact factor: 4.430

4.  Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution.

Authors:  Adam D Ewing; Anthony Gacita; Laura D Wood; Florence Ma; Dongmei Xing; Min-Sik Kim; Srikanth S Manda; Gabriela Abril; Gavin Pereira; Alvin Makohon-Moore; Leendert H J Looijenga; Ad J M Gillis; Ralph H Hruban; Robert A Anders; Katharine E Romans; Akhilesh Pandey; Christine A Iacobuzio-Donahue; Bert Vogelstein; Kenneth W Kinzler; Haig H Kazazian; Szilvia Solyom
Journal:  Genome Res       Date:  2015-08-10       Impact factor: 9.043

5.  Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.

Authors:  Ilona Rousalova; Sulagna Banerjee; Veena Sangwan; Kristen Evenson; Joel A McCauley; Robert Kratzke; Selwyn M Vickers; Ashok Saluja; Jonathan D'Cunha
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

6.  Differential sensitivity to apoptosome apparatus activation in non-small cell lung carcinoma and the lung.

Authors:  Erika Moravcikova; Evzen Krepela; Jan Prochazka; Kamila Benkova; Norbert Pauk
Journal:  Int J Oncol       Date:  2014-03-10       Impact factor: 5.650

7.  Upregulation of CASP9 through NF-κB and Its Target MiR-1276 Contributed to TNFα-promoted Apoptosis of Cancer Cells Induced by Doxorubicin.

Authors:  Fei Zhou; Yun Li; Yisheng Huang; Jian Wu; Qinhan Wu; Hui Zhu; Jinke Wang
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.